Connection

MICHAEL MANCINI to HeLa Cells

This is a "connection" page, showing publications MICHAEL MANCINI has written about HeLa Cells.
Connection Strength

1.701
  1. A Mechanistic High-Content Analysis Assay Using a Chimeric Androgen Receptor That Rapidly Characterizes Androgenic Chemicals. SLAS Discov. 2020 08; 25(7):695-708.
    View in: PubMed
    Score: 0.137
  2. Characterizing properties of non-estrogenic substituted bisphenol analogs using high throughput microscopy and image analysis. PLoS One. 2017; 12(7):e0180141.
    View in: PubMed
    Score: 0.113
  3. Use of HCA in subproteome-immunization and screening of hybridoma supernatants to define distinct antibody binding patterns. Methods. 2016 Mar 01; 96:75-84.
    View in: PubMed
    Score: 0.100
  4. Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays. Chem Biol. 2014 Jun 19; 21(6):743-53.
    View in: PubMed
    Score: 0.091
  5. Systems level-based RNAi screening by high content analysis identifies UBR5 as a regulator of estrogen receptor-a protein levels and activity. Oncogene. 2015 Jan 08; 34(2):154-64.
    View in: PubMed
    Score: 0.089
  6. Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses. Nucleic Acids Res. 2013 Apr; 41(7):4036-48.
    View in: PubMed
    Score: 0.083
  7. High content imaging-based assay to classify estrogen receptor-a ligands based on defined mechanistic outcomes. Gene. 2011 May 15; 477(1-2):42-52.
    View in: PubMed
    Score: 0.072
  8. Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis. J Cell Biol. 2011 Jan 10; 192(1):55-67.
    View in: PubMed
    Score: 0.072
  9. Automated microscopy and image analysis for androgen receptor function. Methods Mol Biol. 2011; 776:313-31.
    View in: PubMed
    Score: 0.072
  10. Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects. PLoS One. 2008; 3(11):e3605.
    View in: PubMed
    Score: 0.062
  11. Activation of estrogen receptor-alpha by E2 or EGF induces temporally distinct patterns of large-scale chromatin modification and mRNA transcription. PLoS One. 2008 May 28; 3(5):e2286.
    View in: PubMed
    Score: 0.060
  12. Estrogen-receptor-alpha exchange and chromatin dynamics are ligand- and domain-dependent. J Cell Sci. 2006 Oct 01; 119(Pt 19):4101-16.
    View in: PubMed
    Score: 0.053
  13. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem. 2006 Jul 01; 98(4):770-88.
    View in: PubMed
    Score: 0.053
  14. High-resolution, high-throughput microscopy analyses of nuclear receptor and coregulator function. Methods Enzymol. 2006; 414:188-210.
    View in: PubMed
    Score: 0.051
  15. Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response. J Cell Biochem. 2004 Jul 01; 92(4):664-78.
    View in: PubMed
    Score: 0.046
  16. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol. 2002 Oct; 4(10):806-10.
    View in: PubMed
    Score: 0.041
  17. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. J Cell Sci. 2001 Apr; 114(Pt 8):1491-503.
    View in: PubMed
    Score: 0.037
  18. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol. 2001 Jan; 3(1):15-23.
    View in: PubMed
    Score: 0.036
  19. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol. 2000 Apr; 14(4):518-34.
    View in: PubMed
    Score: 0.034
  20. Subnuclear dynamics and transcription factor function. J Cell Biochem Suppl. 2000; Suppl 35:99-106.
    View in: PubMed
    Score: 0.033
  21. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet. 1999 May; 8(5):731-41.
    View in: PubMed
    Score: 0.032
  22. Subnuclear partitioning and functional regulation of the Pit-1 transcription factor. J Cell Biochem. 1999 Mar 01; 72(3):322-38.
    View in: PubMed
    Score: 0.032
  23. Measuring Mobility in Chromatin by Intensity-Sorted FCS. Biophys J. 2019 03 19; 116(6):987-999.
    View in: PubMed
    Score: 0.031
  24. Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J Cell Sci. 1998 Dec; 111 ( Pt 23):3497-506.
    View in: PubMed
    Score: 0.031
  25. Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. Mol Endocrinol. 2016 Feb; 30(2):158-72.
    View in: PubMed
    Score: 0.025
  26. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell. 2015 Aug 10; 28(2):240-52.
    View in: PubMed
    Score: 0.025
  27. Differential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysis. PLoS One. 2013; 8(2):e55511.
    View in: PubMed
    Score: 0.021
  28. Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. Adv Exp Med Biol. 2011; 707:63-5.
    View in: PubMed
    Score: 0.018
  29. Ligand-induced large-scale chromatin dynamics as a biosensor for the detection of estrogen receptor subtype selective ligands. Gene. 2010 Jun 15; 458(1-2):37-44.
    View in: PubMed
    Score: 0.017
  30. Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer. Cancer Res. 2010 Jan 15; 70(2):842-51.
    View in: PubMed
    Score: 0.017
  31. Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine. PLoS One. 2009 Dec 09; 4(12):e8179.
    View in: PubMed
    Score: 0.017
  32. Aurora-C kinase supports mitotic progression in the absence of Aurora-B. Cell Cycle. 2009 Sep 15; 8(18):2984-94.
    View in: PubMed
    Score: 0.016
  33. Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1. Mol Endocrinol. 2009 Sep; 23(9):1335-45.
    View in: PubMed
    Score: 0.016
  34. Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305. Breast Cancer Res Treat. 2010 Jan; 119(1):71-85.
    View in: PubMed
    Score: 0.016
  35. Plasma membrane assays and three-compartment image cytometry for high content screening. Assay Drug Dev Technol. 2007 Feb; 5(1):29-48.
    View in: PubMed
    Score: 0.014
  36. Reduced intranuclear mobility of APL fusion proteins accompanies their mislocalization and results in sequestration and decreased mobility of retinoid X receptor alpha. Mol Cell Biol. 2004 May; 24(10):4465-75.
    View in: PubMed
    Score: 0.011
  37. The dynamic mobility of histone H1 is regulated by cyclin/CDK phosphorylation. Mol Cell Biol. 2003 Dec; 23(23):8626-36.
    View in: PubMed
    Score: 0.011
  38. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. Cell Motil Cytoskeleton. 2003 Jun; 55(2):134-46.
    View in: PubMed
    Score: 0.011
  39. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998 Jun; 19(2):148-54.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.